Company Filing History:
Years Active: 2019-2020
Title: Innovations of Zhihui He in Pharmaceutical Development
Introduction
Zhihui He is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for producing important compounds.
Latest Patents
Zhihui He holds two patents that focus on the production of milbemycin, a compound with various applications in agriculture and medicine. His latest patents include a method for producing milbemycin A4 using Streptomyces HS7522, which is deposited in the China General Microbiological Culture Collection Center with an accession number of CGMCC No. 9671 since September 16, 2014. Additionally, he has developed a method for preparing milbemycin A3 by culturing Streptomyces HS7523, which is also deposited in the same collection center with an accession number of CGMCC No. 9672 on the same date.
Career Highlights
Zhihui He is currently associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to innovate and contribute to pharmaceutical research and development. His work has been instrumental in advancing the production techniques of vital pharmaceutical compounds.
Collaborations
Zhihui He has collaborated with notable colleagues such as Yun Teng and Meidong Xu, enhancing the research and development efforts within his field.
Conclusion
Zhihui He is a prominent inventor whose work in pharmaceutical innovations has led to significant advancements in the production of milbemycin compounds. His contributions continue to impact the industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.